X4 Pharmaceuticals Inc. (XFOR)
Market Open
11 Sep, 14:01
NASDAQ (CM) NASDAQ (CM) Primary $
3. 38
-0.02
-0.7353%
$
381.05M Market Cap
- P/E Ratio
- Div Yield
33,446 Volume
-0.63 Eps
$ 3.4
Previous Close 
Want to track XFOR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
X4 Pharmaceuticals Inc. (XFOR) Statistics
Valuation metrics
Market Cap 381.05M
Enterprise value 263.18M
Trailing P/E (ttm) -3.37
Forward P/E -4.32
PEG ratio -0.01
Price/Sales (ttm) 24.05
Price/Book (mrq) 3.28
Enterprise Value/Revenue 16.61
Enterprise Value/EBITDA -3.31
Overview
Shares outstanding 90.91M
Float 64.55M
Shares short 3.12M
% Held by insiders 0.01%
% Held by institutions 0.9%
Average volume (10 days) 168.2K
Average volume (90 days) 1.29M
Price summary
52-Week low 2.8
52-Week high 4.83
Beta 0.33
50-Day moving average 3.94
200-Day moving average 3.97
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 28 Apr 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -5.69%
Operating margin -5.55%
Operational effectiveness
Return on assets -0.36%
Return on equity -0.63%
Income Statement
Revenue (ttm) 35.11M
Revenue per share (ttm) 0.13
Quarterly revenue growth (yoy) 0.79%
Gross profit (ttm) 29.36M
EBITDA -78.61M
Net income to common (ttm) -79.2M
Diluted EPS (ttm) -0.71
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 253M
Total cash per share (mrq) 1.65
Total debt (mrq) 77.28M
Total Debt/Equity (mrq) 0.5
Current ratio (mrq) 11.3%
Book value per share (mrq) 1.23
Cash Flow
Cash flow statement -85.62M
Levered free cash flow (LFCF) -57.36M
